✨
AI Summary
- Richard Pazdur's retirement from the US FDA.
- Discussion of his legacy in oncology drug review.
- Impact of his departure on the FDA's oncology center.
Guests on This Episode
DG
Derrick Gingery
8 podcast appearances
MM
Michael McCaughan
3 podcast appearances
NH
Nielsen Hobbs
8 podcast appearances
SS
Sue Sutter
8 podcast appearances